Peroneal electric transcutaneous neuromodulation versus solifenacin in the treatment of the overactive bladder wet. [PDF]
Krhut J +4 more
europepmc +1 more source
Oxybutynin and tolterodine in a trial for treatment of overactive bladder in Iranian women.
Elham Aziminekoo +5 more
openalex +1 more source
Comparison of Different Treatment Outcomes for Refractory Overactive Bladder: A Systematic Review and Meta-Analysis. [PDF]
Roman MP +9 more
europepmc +1 more source
Trospium Chloride in the Treatment of Overactive Bladder Syndrome and Detrusor Overactivity. [PDF]
Truzzi JC, Sartori MGF, Kemp VL.
europepmc +1 more source
Neurotrophins and Proneurotrophins as Biomarkers for Overactive Bladder Syndrome in Aging Females. [PDF]
Covarrubias C, Cammisotto PG, Campeau L.
europepmc +1 more source
The Role of microRNA in Overactive Bladder: Relationship and Clinical Correlation. [PDF]
Küçüker K +7 more
europepmc +1 more source
Sleep matters: the U-shaped relationship between sleep duration and overactive bladder in U.S. adults. [PDF]
Guan C +8 more
europepmc +1 more source
Revision Rates for Rechargeable Versus Non‐Rechargeable Sacral Neuromodulation Devices in the Management of Overactive Bladder [PDF]
Tal Cohen +8 more
openalex +1 more source
Abnormal Cerebral Perfusion and Functional Connectivity in Women with Overactive Bladder. [PDF]
Chen S +7 more
europepmc +1 more source

